Haemonetics Corporation revenue by segment HAE

Annual Quarterly

Haemonetics Corporation splits its revenue 2 ways in its filings. By operating segments, the largest line in Q2 of fiscal 2027, the quarter ended Sep 26, 2026 was Apheresis at $204.8 million, 57% of the total. By sales mix, the largest line in Q2 of fiscal 2027, the quarter ended Sep 26, 2026 was Plasma Productsand Services at $162.6 million, 45% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 26, 2026	Q2 FY2027 Sep 26, 2026	Q1 FY2027 Jun 27, 2026	Q4 FY2026 Mar 28, 2026	Q3 FY2026 Dec 27, 2025	Q2 FY2026 Sep 27, 2025	Q1 FY2026 Jun 28, 2025	Q4 FY2025 Mar 29, 2025	Q3 FY2025 Dec 28, 2024
Revenue	1,382	358	339	346	339	327	321	331	349
Operating segments
Apheresis	—	205 share 57.2%	191 +5.3% share 56.4%	—	—	—	182 share 56.5%	—	—
Med Surg	—	153 +5.1% share 42.8%	148 +6.0% share 43.6%	160 +8.0% share 46.1%	144 -0.3% share 42.3%	145 share 44.5%	140 share 43.5%	148 share 44.7%	144 share 41.3%
Sales mix
Plasma Productsand Services	—	163 +16.5% share 45.4%	156 +7.2% share 45.8%	130 +2.8% share 37.6%	139 +3.5% share 41.0%	140 share 42.7%	145 share 45.1%	127 share 38.3%	134 share 38.5%
Blood Management Technologies Product And Service	—	92 +7.0% share 25.8%	88 +8.6% share 26.0%	—	—	86 share 26.4%	81 share 25.3%	—	—
Interventional Technologies Product And Service	—	61 +2.4% share 16.9%	60 +2.5% share 17.7%	—	—	59 share 18.0%	58 share 18.2%	—	—
Product And Service Other	—	42 +0.0% share 11.8%	36 -2.4% share 10.5%	—	—	42 share 12.9%	37 share 11.4%	—	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: HAE (NYSE)
Fiscal year ends: April 3
Incorporated in: MA
Headquarters: Boston, MA
SEC filer status: Large accelerated filer
SEC CIK: 313143

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.